German drugmaker Bayer , which acquired seed company Monsanto this year, said it aimed to increase adjusted core earnings to 16 billion euros ($18.1 billion) in 2022, up from an expected 12.2 billion euros this year.
from Reuters: Business News https://ift.tt/2EhqxFu
No comments